Cancer develops with unexpected mutations and causes death in many patients. Among the
different cancer treatment strategies, immunotherapy is promising with the benefits of high …

Carboplatin (CRBP) is a chemotherapeutic agent based on platinum that has applications in
the effective management of ovarian, testis, cervical, neck, head, and small cell lung cancer …

Ovarian cancer is the most common cause of death among gynecological malignancies
globally. Ovarian cancer treatment integrates debulking surgery and systemic therapy …

Background: This study aimed to develop a novel drug formulation using
polybutylcyanoacrylate (PBCA) nanoparticles to deliver cisplatin, a commonly used …

Background: Cisplatin, a platinum complex discovered by Rosenberg in 1969, has long
been known as the first metal-based anticancer agent. Since then, various similar …

Objective: Today, cancer is one the most important challenges in modern medicine.
Meanwhile, breast cancer is one of the most common causes of mortality among cancers …

Background: Cancer is a major problem which has claimed so many lives throughout the
world. Although a number of resources have been utilized for the development of cancer …

Background: Drug delivery systems have been designed to achieve targeted delivery and
control the release rate of the drugs. A serious challenge associated with drug delivery …

Background: Curcumin has long been known to possess therapeutic properties and recent
research have shown that it can inhibit malignant cell proliferation in vivo and in vitro …

Background Methotrexate (MTX) is a common chemotherapeutic drug that inhibits DNA
synthesis and induces apoptosis. Treatment with MTX increased CD73 expression, which …